Investigating the role of obesity, circadian disturbances and lifestyle factors in people with schizophrenia and bipolar disorder: Study protocol for the SOMBER trial
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0306408 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS ONE, 2024. Verfasst von Mikkel Ei Kolind und 8 weiteren Autor:innen. Beteiligte Einrichtung: Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Bipolar Disorder, Circadian Rhythm, Life Style, Obesity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region of Southern Denmark's Fund for Free and Strategic Research, Region Syddanmarks Ph.d.-pulje, Steno Diabetes Center Odense.
Abstract (Originalsprache)
The aim of this study is to investigate circadian rhythms in independently living adults with obesity and mental disease, exploring the interplay between biological markers and lifestyle factors. Eighty participants divided equally into four groups; (i) people with obesity and schizophrenia; (ii) people with obesity and bipolar disorder; (iii) people with obesity without mental disease or sleep disorders, and (iv) people without obesity, mental disease or sleep disorders. Over two consecutive days, participants engage in repeated self-sampling of hair follicle and saliva; concurrently, data is collected on diet, body temperature, light exposure, sleep parameters, and physical activity by accelerometry. Hair follicles are analyzed for circadian gene expression, saliva samples for cortisol and melatonin concentrations. Circadian rhythms are investigated by cosinor analysis. The study employs a participant-tailored sampling schedule to minimize disruptions to daily routine and enhance ecological validity. The methodology aims to provide a comprehensive insight into the factors contributing to circadian disruptions in people with obesity, bipolar disorder and schizophrenia, potentially informing strategies for future management and mitigation. Trial registration: (ClinicalTrials.gov Identifier: NCT05413486 ).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.
- Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
- Open Patient data Explorative Network-OPEN, University of Southern Denmark, Odense, Denmark.
- Department of Endocrinology, Hospital of South West Jutland, Esbjerg, Denmark.
- Department of Clinical Biochemistry, Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark.
- Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
ORCID-Profile: Mikkel Ei Kolind, Rikke Kruse, Lasse K Bak, Kurt Højlund
Förderung
- Region of Southern Denmark's Fund for Free and Strategic Research
- Region Syddanmarks Ph.d.-pulje
- Steno Diabetes Center Odense
- University of Southern Denmark
- Karola Jørgensens Forskningsfond
Zitieren
APA
Kolind, M. E., Kruse, R., Petersen, A. S., Larsen, C. S., Bak, L. K., Højlund, K., Beier, C. P., Stenager, E., & Juhl, C. B. (2024). Investigating the role of obesity, circadian disturbances and lifestyle factors in people with schizophrenia and bipolar disorder: Study protocol for the SOMBER trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0306408
Vancouver
Kolind ME, Kruse R, Petersen AS, Larsen CS, Bak LK, Højlund K, et al. Investigating the role of obesity, circadian disturbances and lifestyle factors in people with schizophrenia and bipolar disorder: Study protocol for the SOMBER trial. PLOS ONE. 2024. doi:10.1371/journal.pone.0306408
BibTeX
@article{Kolind2024,
author = {Kolind, Mikkel Ei and Kruse, Rikke and Petersen, Anni S and Larsen, Charlotte S and Bak, Lasse K and Højlund, Kurt and Beier, Christoph P and Stenager, Elsebeth and Juhl, Claus B},
title = {Investigating the role of obesity, circadian disturbances and lifestyle factors in people with schizophrenia and bipolar disorder: Study protocol for the SOMBER trial},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0306408}
}
EUVIMED